4.5 Review

Immunity to fungi

Journal

CURRENT OPINION IN IMMUNOLOGY
Volume 24, Issue 4, Pages 449-458

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2012.04.007

Keywords

-

Categories

Funding

  1. Robert Sinskey Foundation
  2. American Heart Association
  3. NIH [RO1 AI093808, R01 AI093553, AI40996]
  4. Swiss National Science Foundation [PP00P3_123342]
  5. Swiss Life Anniversary Foundation
  6. ETH Zurich
  7. Swiss National Science Foundation (SNF) [PP00P3_123342] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The global increase in fungal disease burden, the emergence of novel pathogenic fungi, and the lack of fungal vaccines have focused intense interest in elucidating immune defense mechanisms against fungi. Recent studies in animal models and in humans identify an integrated role for C-type lectin and Toll-like receptor signaling in activating innate and adaptive responses that control medically relevant fungi. Beyond the critical role of phagocytes in host defense, the generation and balance of specific T helper subsets contributes to sterilizing immunity. These advances form a basis for the development of fungal vaccines and immune-based therapeutic adjuncts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available